Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00002316 | The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis | PHASE1 | COMPLETED | - | — | — | - | - | Jun 24, 2005 | 11 | United States |
| Name | Type | Description |
|---|---|---|
| Lobradimil | DRUG | - |
| Amphotericin B | DRUG | - |
Inclusion Criteria Concurrent Medication: Allowed: * Up to 1 mg/kg amphotericin B for the current episode of cryptococcal meningitis. Patients must have: * HIV infection. * Acute cryptococcal meningitis. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or condit...